J&J Contests FDA-Proposed Cap With Study Championing High SPF Sunscreens

Johnson & Johnson is strengthening its stance against FDA's proposed maximum for sun protection factors on sunscreen products with a new study refuting the notion that high SPF formulas cannot be accurately and consistently measured.

More from Archive

More from HBW Insight